Boundless Life

How To Microdose GLP-1 (& How To Make Eating Less EASY Even After You Stop Your Peptides) With Geoff Cook of NOOM

36 snips
Jan 1, 2026
Geoff Cook, CEO of Noom and a veteran in the health tech space, dives into the world of GLP-1 microdosing and its impact on weight loss and metabolic health. He shares his personal journey with microdosing, highlighting improved A1C and sustainable weight loss. The discussion delves into the safety and affordability of GLP-1 therapy, the significance of behavior change in maintaining results, and the innovative at-home blood testing that Noom offers for tracking metabolic progress. Geoff emphasizes the broader health benefits beyond appetite suppression, including reduced inflammation and improvements in overall well-being.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

What 'Microdose' Means

  • Noom defines microdose as roughly 2%–25% of a high maintenance GLP‑1 dose.
  • That range equates to about 0.05 mg up to ~0.6 mg of semaglutide versus 2.4 mg maintenance.
ANECDOTE

Geoff's Personal Microdose Results

  • Geoff Cook personally microdosed semaglutide and saw his A1C drop from 5.6 to 5.3.
  • He lost 10 pounds, increased daily activity, and found habit stacking easier while microdosing.
ADVICE

Combine GLP‑1 With Daily Behavior Work

  • Noom bundles behavior change with medication and charges $99 first month then $199 monthly.
  • Use daily micro-habits (steps, protein targets, resistance training) to entrench habits while on microdose.
Get the Snipd Podcast app to discover more snips from this episode
Get the app